中药穴位敷贴治疗支气管哮喘的实验及临床研究
|
摘要
目的：研究小儿防哮敷贴粉穴位敷贴对哮喘豚鼠气道慢性炎症的作用机制及其治疗小儿哮喘的临床疗效。
方法：实验研究：将60只健康豚鼠随机分为正常组、模型组、治疗组1组和2组,每组15只。正常组自然喂养,其余3组采用卵蛋白致敏法建立哮喘豚鼠模型。其中模型组进行哮喘造模,不敷贴治疗；治疗1组于哮喘造模第1天起,在豚鼠背部由颈根部起,做3cm×3cm剃毛,用小儿防哮敷贴粉敷贴治疗,每日1次,每次30分钟,共10天；治疗2组哮喘造模,并于雾化激发第11天起,给予小儿防哮敷贴粉敷贴治疗,方法同治疗1组。实验结束24小时内取血,采用酶联免疫吸附试验双抗体夹心法测定血清IL-4、IFN-γ、LXA4含量。
临床研究：118例哮喘缓解期患儿分别在夏季三伏天(一伏、二伏、三伏的第一天)予以小儿防哮敷贴粉敷贴大椎穴、肺俞穴和膏肓穴治疗,每次敷贴4-6小时。敷贴治疗结束后一年内观察患儿哮喘发作次数、发作程度以及哮喘治疗用药变化。
结果：实验研究：(1)小儿防哮敷贴粉敷贴治疗1组、2组哮喘豚鼠引喘潜伏期较模型组均明显延长,相比有显著性差异(P<0.01)；(2)模型组、敷贴治疗1组和2组豚鼠血清IL-4水平均较正常对照组增高,相比具有显著性差异(P<0.01),但治疗1组、2组与模型组之间比较无显著性差异(P>0.05)；(3)敷贴治疗1组和2组与模型组比较血清IFN-y水平均增高,有显著性差异(P<0.01),但治疗1、2组之间无显著性差异(P>0.05)；(4)敷贴治疗1组豚鼠血清LXA4水平较正常对照组、模型组和治疗2组明显增高,具有显著性差异(P<0.01),但正常组、模型组和治疗2组之间无显著性差异(P<0.01)
临床研究：患者敷贴治疗后哮喘发作次数、发作程度、哮喘控制用药与治疗前相比均明显减少或减轻,有显著性差异(P<0.01)
结论：实验研究：(1)小儿防哮敷贴粉可以有效延长哮喘豚鼠引喘潜伏期,减轻哮喘症状及预防哮喘复发；(2)小儿防哮敷贴粉对哮喘气道慢性炎症密切相关的细胞因子IL-4未见明显影响；(3)小儿防哮敷贴粉对哮喘豚鼠IFN-γ分泌有促进作用,从而间接起到调节Th1/Th2平衡作用；(4)小儿防哮敷贴粉早期敷贴治疗对哮喘豚鼠LXA4释放有较强的促进作用,可调节机体内LXA4发挥广泛的抗炎促消散作用。
临床研究：小儿防哮敷贴粉三伏天穴位敷贴治疗,可有效改善患儿临床症状,减少哮喘发作次数和哮喘控制用药,延长哮喘缓解期。
Objective
Study the influence of Acupoint Application Therapy(AAT) in bronchial asthma(BA) airway inflammation of BA Guinea-Pigs treated with Child Fangxiao Application Powder(CFAP), and the clinical effects of AAT with CFAP in Children with BA.
Method
Experimental research:60 healthy guinea pigs were devided randomly into four groups:normal control group, BA model group, the first group with AAT and the second group. The three groups except normal control grouop were established BA Model Guinea-Pigs allergized with OVA. The BA model group did not make a Acupoint Application Therapy. The first group was treated with CFAP on the special acupoint on the back and neck where the hair was removed in 3cm×3cm square from the first day of BA molding made, Meanwhile, the second group was given the same therapy from the 11th days of aerosol inhalation with OVA. The two groups were treated for 30 minutes, one time per day and ten days continuously. Within 24 hours at the end of experiment, we took the sample blood to detect IL-4, IFN-y and LXA4 with the way of enzyme linked immunosorbent assay-sandwich technique.
Clinical research:118 cases of childhood asthma in remission stage were given Acupoint Application therapy with CFAP on dog days in summer. The acupoints are DAzhui, Feishu and Gaohuang. Time:Every time for 4-6 hours. After the treatment we observe the changes of asthmatic attack times, degree and control drugs within one year.
Result
Experimental research:(1) The period of asthma induction was prolonged obviously in the first group with AAT and the second group(P<0.01); (2)The level of IL-4 in three groups were significantly higher than that of normal control group (P<0.01). However, there was no difference in the level of IL-4 among the three groups (P>0.05); (3) The level of IFN-y in the first group with AAT and the second group were significantly higher than that of BA model group(P<0.01). However, there was no difference between the two treatment groups (P>0.05); (4) The level of LXA4 in the first group with AAT was significantly higher than other three groups (P<0.01). However, there was no difference among the control group, model group and the second group with AAT(P>0.05).
Clinical research:It demonstrated a significant improvement in asthmatic attack times, degree and asthma control drugs with AAT(P<0.01).
Conclusion
Experimental research:(1)The CFAP can effectively prolong the period of guinea pigs asthma induction which may be beneficial to alleviate or prevent the relapse of asthma. (2)The CFAP has no significant influence on the Thlcytokines IL-4 which was correlated well with asthma. (3)The CFAP can contribute to the secretion of IFN-γin guinea pigs with BA which can indirectly regulate Thl/Th2 balance. (4)The CFAP, especially early used in the treatment, can contribute to the secretion of LXA4 in guinea pigs with BA, which has a wide-ranging effects of anti-inflammatory and reducing inflammation.
Clinical research:The AAT with CFAP can improve the symptoms, decrease asthmatic attack times and asthma control drugs which can effectively prolong the remission stage of children with asthma.
方法：实验研究：将60只健康豚鼠随机分为正常组、模型组、治疗组1组和2组,每组15只。正常组自然喂养,其余3组采用卵蛋白致敏法建立哮喘豚鼠模型。其中模型组进行哮喘造模,不敷贴治疗；治疗1组于哮喘造模第1天起,在豚鼠背部由颈根部起,做3cm×3cm剃毛,用小儿防哮敷贴粉敷贴治疗,每日1次,每次30分钟,共10天；治疗2组哮喘造模,并于雾化激发第11天起,给予小儿防哮敷贴粉敷贴治疗,方法同治疗1组。实验结束24小时内取血,采用酶联免疫吸附试验双抗体夹心法测定血清IL-4、IFN-γ、LXA4含量。
临床研究：118例哮喘缓解期患儿分别在夏季三伏天(一伏、二伏、三伏的第一天)予以小儿防哮敷贴粉敷贴大椎穴、肺俞穴和膏肓穴治疗,每次敷贴4-6小时。敷贴治疗结束后一年内观察患儿哮喘发作次数、发作程度以及哮喘治疗用药变化。
结果：实验研究：(1)小儿防哮敷贴粉敷贴治疗1组、2组哮喘豚鼠引喘潜伏期较模型组均明显延长,相比有显著性差异(P<0.01)；(2)模型组、敷贴治疗1组和2组豚鼠血清IL-4水平均较正常对照组增高,相比具有显著性差异(P<0.01),但治疗1组、2组与模型组之间比较无显著性差异(P>0.05)；(3)敷贴治疗1组和2组与模型组比较血清IFN-y水平均增高,有显著性差异(P<0.01),但治疗1、2组之间无显著性差异(P>0.05)；(4)敷贴治疗1组豚鼠血清LXA4水平较正常对照组、模型组和治疗2组明显增高,具有显著性差异(P<0.01),但正常组、模型组和治疗2组之间无显著性差异(P<0.01)
临床研究：患者敷贴治疗后哮喘发作次数、发作程度、哮喘控制用药与治疗前相比均明显减少或减轻,有显著性差异(P<0.01)
结论：实验研究：(1)小儿防哮敷贴粉可以有效延长哮喘豚鼠引喘潜伏期,减轻哮喘症状及预防哮喘复发；(2)小儿防哮敷贴粉对哮喘气道慢性炎症密切相关的细胞因子IL-4未见明显影响；(3)小儿防哮敷贴粉对哮喘豚鼠IFN-γ分泌有促进作用,从而间接起到调节Th1/Th2平衡作用；(4)小儿防哮敷贴粉早期敷贴治疗对哮喘豚鼠LXA4释放有较强的促进作用,可调节机体内LXA4发挥广泛的抗炎促消散作用。
临床研究：小儿防哮敷贴粉三伏天穴位敷贴治疗,可有效改善患儿临床症状,减少哮喘发作次数和哮喘控制用药,延长哮喘缓解期。
Objective
Study the influence of Acupoint Application Therapy(AAT) in bronchial asthma(BA) airway inflammation of BA Guinea-Pigs treated with Child Fangxiao Application Powder(CFAP), and the clinical effects of AAT with CFAP in Children with BA.
Method
Experimental research:60 healthy guinea pigs were devided randomly into four groups:normal control group, BA model group, the first group with AAT and the second group. The three groups except normal control grouop were established BA Model Guinea-Pigs allergized with OVA. The BA model group did not make a Acupoint Application Therapy. The first group was treated with CFAP on the special acupoint on the back and neck where the hair was removed in 3cm×3cm square from the first day of BA molding made, Meanwhile, the second group was given the same therapy from the 11th days of aerosol inhalation with OVA. The two groups were treated for 30 minutes, one time per day and ten days continuously. Within 24 hours at the end of experiment, we took the sample blood to detect IL-4, IFN-y and LXA4 with the way of enzyme linked immunosorbent assay-sandwich technique.
Clinical research:118 cases of childhood asthma in remission stage were given Acupoint Application therapy with CFAP on dog days in summer. The acupoints are DAzhui, Feishu and Gaohuang. Time:Every time for 4-6 hours. After the treatment we observe the changes of asthmatic attack times, degree and control drugs within one year.
Result
Experimental research:(1) The period of asthma induction was prolonged obviously in the first group with AAT and the second group(P<0.01); (2)The level of IL-4 in three groups were significantly higher than that of normal control group (P<0.01). However, there was no difference in the level of IL-4 among the three groups (P>0.05); (3) The level of IFN-y in the first group with AAT and the second group were significantly higher than that of BA model group(P<0.01). However, there was no difference between the two treatment groups (P>0.05); (4) The level of LXA4 in the first group with AAT was significantly higher than other three groups (P<0.01). However, there was no difference among the control group, model group and the second group with AAT(P>0.05).
Clinical research:It demonstrated a significant improvement in asthmatic attack times, degree and asthma control drugs with AAT(P<0.01).
Conclusion
Experimental research:(1)The CFAP can effectively prolong the period of guinea pigs asthma induction which may be beneficial to alleviate or prevent the relapse of asthma. (2)The CFAP has no significant influence on the Thlcytokines IL-4 which was correlated well with asthma. (3)The CFAP can contribute to the secretion of IFN-γin guinea pigs with BA which can indirectly regulate Thl/Th2 balance. (4)The CFAP, especially early used in the treatment, can contribute to the secretion of LXA4 in guinea pigs with BA, which has a wide-ranging effects of anti-inflammatory and reducing inflammation.
Clinical research:The AAT with CFAP can improve the symptoms, decrease asthmatic attack times and asthma control drugs which can effectively prolong the remission stage of children with asthma.
引文
[1]Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease[J]. Nat Rev Immunol,2008,8:183-192.
[2]Lundback B, Dahl R. Assessment of asthma control and its impact on optimal treatment strategy [J].Allergy,2007,62(6):611-619.
[3]Fixman ED, Stewart A, Martin JG. Basic mechanisms of development of airway structural changes in asthma[J]. Eur Respir J,2007,29(2):379-389.
[4]Levy BD, Serhan CN. Exploring new approaches to the treatment of asthma: potential roles for lipoxins and aspirin triggered lipid mediators[J]. Drugs Today.2003.39(5):373-384.
[5]Schmidt BA. Szczeklik W. Drazen JM. et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4[J]. Nat M ed.2002.8(9): 1018-1023.
[6]殷佩玲,吴升华.脂氧素与哮喘[J].国际呼吸杂志,2006,26(8)：595—599.
[7]康雅媛.冬病夏治中药穴位贴敷法治疗儿童哮喘缓解期100例[J].江西中医药,2009,4(4)：55.
[8]孙建,尤菊松,唐艳芬,等.吴氏发泡膏穴位贴敷对50例支气管哮喘缓解期患者免疫功能的影响[J].江苏中医药,2009,41(5)：23-24.
[9]全国儿童哮喘防治协作组.中国城区儿童哮喘患病率调查[J].中华儿科杂志,2003,41(2)：123.
[10]Taussig LM, Wriqht AL, Holberq C, et al. Tuscon children respiratory study: 1980 to present[J]. J Allergy Clin lmmtmol,2003,111(4):661-675.
[11]Knufman JE, Sorkness CA, Lemanske RF Jr, et al. Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma[J]. Allergy Clin Immunol,2009,123(2):411-416.
[12]陈欣,林江涛.我国支气管哮喘防治现状[J].内科急危重症杂志,2008,14(5)：225-226.
[13]李明华,殷凯生,朱栓立主编.哮喘病学.北京：人民卫生出版社,1998： 3.
[14]沈晓明,王卫平主编.儿科学.北京：人民卫生出版社,2009：266-267.
[15]Masuda K, Aota Y, Much leman C, et al. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. The collaborative study on the genetics of asthma(CSGA)[J]. Nat Genetics,1997,15(3):389-392.
[16]Blumenthal MN, Banks SS, Bleecker R, et al. Collaborative studies on the genetics of asthma-National Heart, Lung and Blood Institute[J]. Clin Exp Allergy, 1995,25(Suppl 2):29-32.
[17]HOMER R J, ELI AS J A. Airway remodeling in asthma:therapeutic implications of mechanisms. Physiology (Bethesda),2005,20 (1):28-35.
[18]Kaliner MA. Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids:A comparison of ciclesonide and fluticasone propionate[J]. clin Ther,2006,28(3):319-331.
[19]Pedersen SE, Bateman ED, Bousquet J, et al. Deteminants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining optimal Asthma control study[J]. J Allergy clin Immunol,2007,120(5): 1036-1042.
[20]Strunk RC, Bollmberg GR. Omalizumab for asthma[J]. N Engl J Med,2006, 354(25):2689-2695.
[21]廖世才.小儿哮喘活血化瘀法治疗体会[J].江西中医药,1997,28(6)：33.
[22]洪霞,廖宝军.从痰瘀论治小儿哮喘116例分析[J].陕西中医函授,2000,(5)：41.
[23]邵花荣.川芎嗪静脉滴注治疗发作期支气管哮喘[J].上海中医药杂志,1990,(8)：18.
[24]李荣,刘听,蒋红雨等.小儿哮喘甲襞微循环及血液流变学观察[J].中国中西医结合杂志,1997,17(9)：525.
[25]陈立翠.补肾法治疗小儿支气管哮喘探讨[J].成都中医药大学学报,1999,22(3)：5.
[26]沈自尹.补肾法预防哮喘的变态和非变态反应机制研究.中西医结合杂志, 1989,9(2)：82.
[27]王鹏,陈铁清.张德新主编.中医哮病学.北京：中国医药科技出版社,2002年.
[28]史锁芳.哮喘“夙根”探讨.中医药学报,1994,(3)：6.
[29]彭红星.陈陶后教授治疗小儿哮喘经验.山西中医,1995,11(2)：5.
[30]胡国俊.胡翘武治疗支气管哮喘的经验.中国医药学报,1993,8(5)：56.
[31]贺显庭.化痰祛瘀法治疗小儿哮喘120例.湖南中医杂志,1997,13(4)：41.
[32]王明明,胡英同.汪受传从肺论治小儿哮喘缓解期的经验[J].辽宁中医杂志,2001,28(8)：466.
[33]杜海华.小儿哮喘缓解期哮喘Ⅱ号疗效分析[J].中医药学刊,2003,21(7)：1196.
[34]张洁,施光其.黄芪六君子汤治疗哮喘缓解期85例临床观察[J].山东中医杂志,2004,23(4)：204-205.
[35]单昌涛.加味补中益气汤治疗支气管哮喘缓解期的临床观察[J].河北中医,2005,27(8)：604.
[36]柯新桥.补肾防喘述要[J].湖北中医杂志,1997,19(6)：3-5.
[37]陆鸿元.儿科治喘名家徐仲才[J].上海中医药杂志,1989,(3)：27-28.
[38]沈自尹,等.温阳片预防支气管哮喘季节性发作及其原理研究[J].中西医结合杂志,1986,(1)：17-19.
[39]黎世明.黎炳南教授治疗顽固性哮喘经验[J].新中医,1994,(2)：11.
[40]胡兴明.石蕴停老中医学术经验[J].新中医,1985,17(12)：9.
[41]陈进,罗光亮.攻补兼施治疗小儿哮喘[J].中医杂志,1995,36(11)：666-668.
[42]邵征洋,连俊兰.止喘膏敷贴防治儿童支气管哮喘70例[J].浙江中医杂志,2009,44(6)：438.
[43]王岐黄,王乐文,杨章兴.平喘膏穴位敷贴防治支气管哮喘160例临床观察[J].中国中医药导报,2008,5(20)：92.
[44]鄢素琪,刘昌玉,金建年,等.喘敷灵穴位敷贴防治儿童哮喘80例临床 研究[J].中医杂志,2008,49(3)：221-223.
[45]张丽,汪兴洲.自血穴位注射治疗儿童支气管哮喘26例[J].浙江中医杂志,2007,42(7)：419.
[46]陈具堂.穴位注射治疗支气管哮喘73例[J].中国针灸,2007,27(1)：75.
[47]项春福.穴位注射治疗支气管哮喘42例[J].现代中西医结合杂志,2007,16(3)：346-347.
[48]涂新生.穴位埋线治疗支气管哮喘100例[J].中医外治杂志,2009,18(2)：47.
[49]张文义.平行针药线介入治疗支气管哮喘100例[J].中医外治杂志,2007,16(1)：39.
[50]王又平.针灸治疗哮喘50例临床观察[J].光明中医,2008,23(1)：23-24.
[51]黄传萍.药物灸治疗小儿支气管哮喘50例[J].吉林中医药,2007,27(3)：37-38.
[52]王丽英.推拿在防止小儿哮喘复发中的应用[J].实用中医内科杂志,2005,19(4)：384.
[53]季林香.穴位按摩合消喘膏敷贴冶疗哮喘247例护理[J].浙江中医学院学报,2006,30(1)：89-92.
[54]邵雪英,俞琦.足穴推拿防治小儿哮喘38例效果评价[J].浙江中医杂志,2009,44(6)：447-448.
[55]高继新.中药雾化吸入治疗小儿发作期哮喘18例[J].长春中医药大学学报,2007,23(4)：79.
[56]王妍炜.中药雾化吸入治疗小儿哮喘发作疗效观察[J].中国中医急症,2006,15(8)：832-839.
[57]姜之炎.儿童哮喘直肠凝胶剂治疗哮喘30例[J].上海中医药杂志,2001,(5)：29-30.
[58]肖东伟,高明利.穴位贴敷理论基础浅探[J].辽宁中医药大学学报,2008,10(5)：127.
[59]于雪峰,倪力强,乔世举.中药穴位贴敷对哮喘患者肺功能的影响.中国中医药信息杂志,2003,10(9)：73-74.
[60]白丽君,马文.中药定喘膏穴位贴敷治疗支气管哮喘缓解期48例[J].中医药临床杂志,2005,17(4)：381.
[61]韩慧敏.冬病夏治穴位敷贴法治疗老年哮喘缓解期[J].中国康复医学杂志,2008,23(4)：240.
[62]袁维真.哮喘贴治疗支气管哮喘100例疗效观察及护理[J].吉林中医药,2006,26(9)：21-22.
[63]单翠英,林忠嗣,卞镝.中药穴位贴敷治疗儿童哮喘的临床及免疫机制[J].中华中医药学刊,2007,25(4)：845—846.
[64]白晓红,邵功利,王雪峰.伏九贴膏防治小儿哮喘的临床研究探要[J].中医药学刊,2004：22(9)：1637.
[65]张静,于雪峰,刘文华.伏九天中药穴位敷贴防治支气管哮喘临床观察[J].辽宁中医杂志,2001；(4)：247-248.
[66]徐绿萍,周近放.穴位敷贴治疗哮喘218例.上海针灸杂志,2002；21(1)：24.
[67]姚红,董娟,张盘德,等.中药穴位敷贴疗法对支气管哮喘患者炎症细胞水平的影响[J].广州中医药大学学报,2007,24(4)：289—292.
[68]樊学忠,刘建平.中药穴位敷贴治疗支气管哮喘不同季节不同证型的疗效分析.中国针灸,2001：21(3)：139.
[69]倪伟,于素霞,王宏长,等.穴位敷贴疗法治疗寒性哮喘.上海针灸杂志,2001；20(3)：10.
[70]赖新生,李月梅,张家维.天灸对哮喘患者可溶性IL-2受体及T淋巴细胞亚群的影响.中国针灸,2000,20(1)：33-34.
[71]陆伟珍.中药穴位敷贴对哮喘病人细胞因子IL-4、IL-10及IL-13的影响[J].辽宁中医杂志,2007,34(2)：129-130.
[72]蔡建新,叶冬兰,梁淼.咳喘三伏贴防治小儿哮喘临床观察[J].光明中医,2008,23(2)：143-145.
[73]Mosmann TR, Sad S. The expanding universe of T-cell subsets:Thl, Th2 and more. Immunol Today,1996,17(3):138-146.
[74]Kunzmann V, Bauer E, Feurle J, et al. Stimulation of gammadelta T cells by aminobisphonates and induction of antiplasma ceU activity in multiple myeloma. Blood,2000,96:384-392.
[75]殷佩玲,吴升华.脂氧素与哮喘.国际呼吸杂志,2006,26(8)：595-599.
[76]Schmidt BA. Szczeklik W. Drazen JM. et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4. Nat M ed.2002,8(9): 1018-1023.
[77]Levy BD, Serhan CN. Exploring new approaches to the treatment of asthma: potential roles for lipoxins and aspirin triggered lipid mediators. Drugs Today.2003.39(5):373-384.
[78]Bandeira-Melo C et al. J Immunol,2000,164(5):2267-2271.] [Bandeira-Melo Cetal. J Immunol,2000,164(2):1029-1036.
[79]胡作为,周电光,周燕萍,等.中药止哮平喘方抗哮喘豚鼠模型气道炎症的实验研究[J].广州中医药大学学报,2004,21(1)：40—43.
[80]李国豪,徐邦牢,雷秀霞,等.壁虎粉对哮喘豚鼠模型干预作用的实验研究[J].热带医学杂志,2007,7(2)：143-145.
[81]中华医学会儿科学分会呼吸学组.儿童支气管哮喘诊断与防治指南(2008年修订),《中华儿科杂志》编辑委员会.
[82]汪受传主编.中医儿科学.北京：中国中医药出版社出版,2007年.
[83]何会霞,李自红.支气管哮喘实验动物模型的研究进展.中国老年学杂志,2008,28(20)：2074-2076.
[84]沈华浩,王苹莉.如何评价哮喘动物模型.医学与哲学(临床决策论坛版),2007,28(8)：13-15.
[85]颜晓燕,童志远.哮喘动物模型研究现状.成都医学院学报,2007,2(2)：156-159.
[86]Temeleovski J, Hogan SP, Shepherd DP, et al. An improved murine model of asthma:selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax,1998, 53:849-856.
[87]戴继宏,谭毅,符州.哮喘动物模型的研究现状.中国实验动物学杂志,2001,11(3)：167-171.
[88]徐立,范欣生,何胜旭.复方辛夷口服液对卵蛋白致敏豚鼠支气管哮喘的影响[J].南京中医药大学学报,2004,20(2)：104-106.
[89]杨继兵,朱永忠,刘隆棣,等.芩荑合剂治疗实验性哮喘动物模型气道变应性炎症的机理研究[J].中华中医药学刊,2007；25(1)：90-2.
[90]Holgate ST, Djukanovic R, Casale T, et al.Anti-immnoglobulin E treament with omalizumab in allergic diseases:an update on anti-inflammatory activity and clinical efficacy[J]. Clin Exp Allergy,2005,35(4):408.
[91]赵绪韬译.支气管哮喘药物治疗指南[J].世界临床药物,2006,27(3)：172-175.
[92]Ashwell JD, Lu FW, Vacchio MS, et al. Glucocorticoid in Tcell development and function. Annu Reu Immunol,2000,10(5):309-345.
[93]姚红,童娟,王铮,等.中药穴位敷贴疗法对哮喘大鼠肺组织中白细胞介素-4、γ干扰素表达的影响.针刺研究,2007,32(3)：174-178.
[94]张力,万敬员,叶笃筠.脂氧素与炎症消退.生命的化学,2004,24(1)：61-63.
[95]Levy BD, Serhan CN. Exploring new approaches to the treatment of asthma: potential roles for lipoxins and aspirin triggered lipid mediators. Drugs Today.2003,39(5):373-384.
[96]欧敏锐,吴国欣,杜跃鑫.中药白介子研究概述.海峡药学,2001：13(2)：8.
[97]高雪,曲敬来.中药穴位贴敷治疗支气管哮喘机理探讨.针灸临床杂志,1998；14(8)：36.
[98]陈卫华,孔巧玲.针刺大椎穴治疗哮喘的即效性观察.针刺研究[J],1998,23(3)：199-200.
[99]朱文莲,刘仁权.艾灸大椎穴对免疫低下小鼠吞噬细胞吞噬功能的影响[J].北京中医药大学学报,2005,28(1)：89-90.
[100]胡志光,尹钢林.针刺对支气管哮喘患者T细胞亚群和IL-4的影响[J].中国针灸,1999,19(2)：111-112.
[101]张压西,陈友梅.针刺肺俞穴改善肺功能时效关系研究.中国针灸, 1997.(10)：581-582.
[102]陈铭,蔡宗敏.节气灸与支气管哮喘肺功能变化关系初探.中国针灸.2000,(3)155-156.
[2]Lundback B, Dahl R. Assessment of asthma control and its impact on optimal treatment strategy [J].Allergy,2007,62(6):611-619.
[3]Fixman ED, Stewart A, Martin JG. Basic mechanisms of development of airway structural changes in asthma[J]. Eur Respir J,2007,29(2):379-389.
[4]Levy BD, Serhan CN. Exploring new approaches to the treatment of asthma: potential roles for lipoxins and aspirin triggered lipid mediators[J]. Drugs Today.2003.39(5):373-384.
[5]Schmidt BA. Szczeklik W. Drazen JM. et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4[J]. Nat M ed.2002.8(9): 1018-1023.
[6]殷佩玲,吴升华.脂氧素与哮喘[J].国际呼吸杂志,2006,26(8)：595—599.
[7]康雅媛.冬病夏治中药穴位贴敷法治疗儿童哮喘缓解期100例[J].江西中医药,2009,4(4)：55.
[8]孙建,尤菊松,唐艳芬,等.吴氏发泡膏穴位贴敷对50例支气管哮喘缓解期患者免疫功能的影响[J].江苏中医药,2009,41(5)：23-24.
[9]全国儿童哮喘防治协作组.中国城区儿童哮喘患病率调查[J].中华儿科杂志,2003,41(2)：123.
[10]Taussig LM, Wriqht AL, Holberq C, et al. Tuscon children respiratory study: 1980 to present[J]. J Allergy Clin lmmtmol,2003,111(4):661-675.
[11]Knufman JE, Sorkness CA, Lemanske RF Jr, et al. Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma[J]. Allergy Clin Immunol,2009,123(2):411-416.
[12]陈欣,林江涛.我国支气管哮喘防治现状[J].内科急危重症杂志,2008,14(5)：225-226.
[13]李明华,殷凯生,朱栓立主编.哮喘病学.北京：人民卫生出版社,1998： 3.
[14]沈晓明,王卫平主编.儿科学.北京：人民卫生出版社,2009：266-267.
[15]Masuda K, Aota Y, Much leman C, et al. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. The collaborative study on the genetics of asthma(CSGA)[J]. Nat Genetics,1997,15(3):389-392.
[16]Blumenthal MN, Banks SS, Bleecker R, et al. Collaborative studies on the genetics of asthma-National Heart, Lung and Blood Institute[J]. Clin Exp Allergy, 1995,25(Suppl 2):29-32.
[17]HOMER R J, ELI AS J A. Airway remodeling in asthma:therapeutic implications of mechanisms. Physiology (Bethesda),2005,20 (1):28-35.
[18]Kaliner MA. Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids:A comparison of ciclesonide and fluticasone propionate[J]. clin Ther,2006,28(3):319-331.
[19]Pedersen SE, Bateman ED, Bousquet J, et al. Deteminants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining optimal Asthma control study[J]. J Allergy clin Immunol,2007,120(5): 1036-1042.
[20]Strunk RC, Bollmberg GR. Omalizumab for asthma[J]. N Engl J Med,2006, 354(25):2689-2695.
[21]廖世才.小儿哮喘活血化瘀法治疗体会[J].江西中医药,1997,28(6)：33.
[22]洪霞,廖宝军.从痰瘀论治小儿哮喘116例分析[J].陕西中医函授,2000,(5)：41.
[23]邵花荣.川芎嗪静脉滴注治疗发作期支气管哮喘[J].上海中医药杂志,1990,(8)：18.
[24]李荣,刘听,蒋红雨等.小儿哮喘甲襞微循环及血液流变学观察[J].中国中西医结合杂志,1997,17(9)：525.
[25]陈立翠.补肾法治疗小儿支气管哮喘探讨[J].成都中医药大学学报,1999,22(3)：5.
[26]沈自尹.补肾法预防哮喘的变态和非变态反应机制研究.中西医结合杂志, 1989,9(2)：82.
[27]王鹏,陈铁清.张德新主编.中医哮病学.北京：中国医药科技出版社,2002年.
[28]史锁芳.哮喘“夙根”探讨.中医药学报,1994,(3)：6.
[29]彭红星.陈陶后教授治疗小儿哮喘经验.山西中医,1995,11(2)：5.
[30]胡国俊.胡翘武治疗支气管哮喘的经验.中国医药学报,1993,8(5)：56.
[31]贺显庭.化痰祛瘀法治疗小儿哮喘120例.湖南中医杂志,1997,13(4)：41.
[32]王明明,胡英同.汪受传从肺论治小儿哮喘缓解期的经验[J].辽宁中医杂志,2001,28(8)：466.
[33]杜海华.小儿哮喘缓解期哮喘Ⅱ号疗效分析[J].中医药学刊,2003,21(7)：1196.
[34]张洁,施光其.黄芪六君子汤治疗哮喘缓解期85例临床观察[J].山东中医杂志,2004,23(4)：204-205.
[35]单昌涛.加味补中益气汤治疗支气管哮喘缓解期的临床观察[J].河北中医,2005,27(8)：604.
[36]柯新桥.补肾防喘述要[J].湖北中医杂志,1997,19(6)：3-5.
[37]陆鸿元.儿科治喘名家徐仲才[J].上海中医药杂志,1989,(3)：27-28.
[38]沈自尹,等.温阳片预防支气管哮喘季节性发作及其原理研究[J].中西医结合杂志,1986,(1)：17-19.
[39]黎世明.黎炳南教授治疗顽固性哮喘经验[J].新中医,1994,(2)：11.
[40]胡兴明.石蕴停老中医学术经验[J].新中医,1985,17(12)：9.
[41]陈进,罗光亮.攻补兼施治疗小儿哮喘[J].中医杂志,1995,36(11)：666-668.
[42]邵征洋,连俊兰.止喘膏敷贴防治儿童支气管哮喘70例[J].浙江中医杂志,2009,44(6)：438.
[43]王岐黄,王乐文,杨章兴.平喘膏穴位敷贴防治支气管哮喘160例临床观察[J].中国中医药导报,2008,5(20)：92.
[44]鄢素琪,刘昌玉,金建年,等.喘敷灵穴位敷贴防治儿童哮喘80例临床 研究[J].中医杂志,2008,49(3)：221-223.
[45]张丽,汪兴洲.自血穴位注射治疗儿童支气管哮喘26例[J].浙江中医杂志,2007,42(7)：419.
[46]陈具堂.穴位注射治疗支气管哮喘73例[J].中国针灸,2007,27(1)：75.
[47]项春福.穴位注射治疗支气管哮喘42例[J].现代中西医结合杂志,2007,16(3)：346-347.
[48]涂新生.穴位埋线治疗支气管哮喘100例[J].中医外治杂志,2009,18(2)：47.
[49]张文义.平行针药线介入治疗支气管哮喘100例[J].中医外治杂志,2007,16(1)：39.
[50]王又平.针灸治疗哮喘50例临床观察[J].光明中医,2008,23(1)：23-24.
[51]黄传萍.药物灸治疗小儿支气管哮喘50例[J].吉林中医药,2007,27(3)：37-38.
[52]王丽英.推拿在防止小儿哮喘复发中的应用[J].实用中医内科杂志,2005,19(4)：384.
[53]季林香.穴位按摩合消喘膏敷贴冶疗哮喘247例护理[J].浙江中医学院学报,2006,30(1)：89-92.
[54]邵雪英,俞琦.足穴推拿防治小儿哮喘38例效果评价[J].浙江中医杂志,2009,44(6)：447-448.
[55]高继新.中药雾化吸入治疗小儿发作期哮喘18例[J].长春中医药大学学报,2007,23(4)：79.
[56]王妍炜.中药雾化吸入治疗小儿哮喘发作疗效观察[J].中国中医急症,2006,15(8)：832-839.
[57]姜之炎.儿童哮喘直肠凝胶剂治疗哮喘30例[J].上海中医药杂志,2001,(5)：29-30.
[58]肖东伟,高明利.穴位贴敷理论基础浅探[J].辽宁中医药大学学报,2008,10(5)：127.
[59]于雪峰,倪力强,乔世举.中药穴位贴敷对哮喘患者肺功能的影响.中国中医药信息杂志,2003,10(9)：73-74.
[60]白丽君,马文.中药定喘膏穴位贴敷治疗支气管哮喘缓解期48例[J].中医药临床杂志,2005,17(4)：381.
[61]韩慧敏.冬病夏治穴位敷贴法治疗老年哮喘缓解期[J].中国康复医学杂志,2008,23(4)：240.
[62]袁维真.哮喘贴治疗支气管哮喘100例疗效观察及护理[J].吉林中医药,2006,26(9)：21-22.
[63]单翠英,林忠嗣,卞镝.中药穴位贴敷治疗儿童哮喘的临床及免疫机制[J].中华中医药学刊,2007,25(4)：845—846.
[64]白晓红,邵功利,王雪峰.伏九贴膏防治小儿哮喘的临床研究探要[J].中医药学刊,2004：22(9)：1637.
[65]张静,于雪峰,刘文华.伏九天中药穴位敷贴防治支气管哮喘临床观察[J].辽宁中医杂志,2001；(4)：247-248.
[66]徐绿萍,周近放.穴位敷贴治疗哮喘218例.上海针灸杂志,2002；21(1)：24.
[67]姚红,董娟,张盘德,等.中药穴位敷贴疗法对支气管哮喘患者炎症细胞水平的影响[J].广州中医药大学学报,2007,24(4)：289—292.
[68]樊学忠,刘建平.中药穴位敷贴治疗支气管哮喘不同季节不同证型的疗效分析.中国针灸,2001：21(3)：139.
[69]倪伟,于素霞,王宏长,等.穴位敷贴疗法治疗寒性哮喘.上海针灸杂志,2001；20(3)：10.
[70]赖新生,李月梅,张家维.天灸对哮喘患者可溶性IL-2受体及T淋巴细胞亚群的影响.中国针灸,2000,20(1)：33-34.
[71]陆伟珍.中药穴位敷贴对哮喘病人细胞因子IL-4、IL-10及IL-13的影响[J].辽宁中医杂志,2007,34(2)：129-130.
[72]蔡建新,叶冬兰,梁淼.咳喘三伏贴防治小儿哮喘临床观察[J].光明中医,2008,23(2)：143-145.
[73]Mosmann TR, Sad S. The expanding universe of T-cell subsets:Thl, Th2 and more. Immunol Today,1996,17(3):138-146.
[74]Kunzmann V, Bauer E, Feurle J, et al. Stimulation of gammadelta T cells by aminobisphonates and induction of antiplasma ceU activity in multiple myeloma. Blood,2000,96:384-392.
[75]殷佩玲,吴升华.脂氧素与哮喘.国际呼吸杂志,2006,26(8)：595-599.
[76]Schmidt BA. Szczeklik W. Drazen JM. et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4. Nat M ed.2002,8(9): 1018-1023.
[77]Levy BD, Serhan CN. Exploring new approaches to the treatment of asthma: potential roles for lipoxins and aspirin triggered lipid mediators. Drugs Today.2003.39(5):373-384.
[78]Bandeira-Melo C et al. J Immunol,2000,164(5):2267-2271.] [Bandeira-Melo Cetal. J Immunol,2000,164(2):1029-1036.
[79]胡作为,周电光,周燕萍,等.中药止哮平喘方抗哮喘豚鼠模型气道炎症的实验研究[J].广州中医药大学学报,2004,21(1)：40—43.
[80]李国豪,徐邦牢,雷秀霞,等.壁虎粉对哮喘豚鼠模型干预作用的实验研究[J].热带医学杂志,2007,7(2)：143-145.
[81]中华医学会儿科学分会呼吸学组.儿童支气管哮喘诊断与防治指南(2008年修订),《中华儿科杂志》编辑委员会.
[82]汪受传主编.中医儿科学.北京：中国中医药出版社出版,2007年.
[83]何会霞,李自红.支气管哮喘实验动物模型的研究进展.中国老年学杂志,2008,28(20)：2074-2076.
[84]沈华浩,王苹莉.如何评价哮喘动物模型.医学与哲学(临床决策论坛版),2007,28(8)：13-15.
[85]颜晓燕,童志远.哮喘动物模型研究现状.成都医学院学报,2007,2(2)：156-159.
[86]Temeleovski J, Hogan SP, Shepherd DP, et al. An improved murine model of asthma:selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax,1998, 53:849-856.
[87]戴继宏,谭毅,符州.哮喘动物模型的研究现状.中国实验动物学杂志,2001,11(3)：167-171.
[88]徐立,范欣生,何胜旭.复方辛夷口服液对卵蛋白致敏豚鼠支气管哮喘的影响[J].南京中医药大学学报,2004,20(2)：104-106.
[89]杨继兵,朱永忠,刘隆棣,等.芩荑合剂治疗实验性哮喘动物模型气道变应性炎症的机理研究[J].中华中医药学刊,2007；25(1)：90-2.
[90]Holgate ST, Djukanovic R, Casale T, et al.Anti-immnoglobulin E treament with omalizumab in allergic diseases:an update on anti-inflammatory activity and clinical efficacy[J]. Clin Exp Allergy,2005,35(4):408.
[91]赵绪韬译.支气管哮喘药物治疗指南[J].世界临床药物,2006,27(3)：172-175.
[92]Ashwell JD, Lu FW, Vacchio MS, et al. Glucocorticoid in Tcell development and function. Annu Reu Immunol,2000,10(5):309-345.
[93]姚红,童娟,王铮,等.中药穴位敷贴疗法对哮喘大鼠肺组织中白细胞介素-4、γ干扰素表达的影响.针刺研究,2007,32(3)：174-178.
[94]张力,万敬员,叶笃筠.脂氧素与炎症消退.生命的化学,2004,24(1)：61-63.
[95]Levy BD, Serhan CN. Exploring new approaches to the treatment of asthma: potential roles for lipoxins and aspirin triggered lipid mediators. Drugs Today.2003,39(5):373-384.
[96]欧敏锐,吴国欣,杜跃鑫.中药白介子研究概述.海峡药学,2001：13(2)：8.
[97]高雪,曲敬来.中药穴位贴敷治疗支气管哮喘机理探讨.针灸临床杂志,1998；14(8)：36.
[98]陈卫华,孔巧玲.针刺大椎穴治疗哮喘的即效性观察.针刺研究[J],1998,23(3)：199-200.
[99]朱文莲,刘仁权.艾灸大椎穴对免疫低下小鼠吞噬细胞吞噬功能的影响[J].北京中医药大学学报,2005,28(1)：89-90.
[100]胡志光,尹钢林.针刺对支气管哮喘患者T细胞亚群和IL-4的影响[J].中国针灸,1999,19(2)：111-112.
[101]张压西,陈友梅.针刺肺俞穴改善肺功能时效关系研究.中国针灸, 1997.(10)：581-582.
[102]陈铭,蔡宗敏.节气灸与支气管哮喘肺功能变化关系初探.中国针灸.2000,(3)155-156.